Peptides / Sermorelin
Sermorelin
(Geref, GRF 1-29, Sermorelin acetate)T2peptideliterature
Biomarker Effects
Growth hormone
↑ large
Stimulates pituitary GH release
IGF-1
↑ moderate
GH/IGF-1 axis activation
IGFBP-3
↑ moderate
GH-mediated binding proteins
Fasting glucose
↑ small
GH-mediated insulin resistance
Dosing & Pharmacokinetics
Typical Dose0.1 mg
Frequencydaily
Routeclinician-directed
Half-Life18 min
Safety & Evidence
Sermorelin is a synthetic GHRH analog (GRF 1-29) approved for growth hormone deficiency testing. Short half-life (~12-14 minutes). Not FDA-approved for anti-aging.
Sources
Track Sermorelin precisely in the Vivy app.
Your precision instrument awaits.
Download Vivy